GENEVIEVE PROTOCOL Trademark

Trademark Overview

On Wednesday, February 6, 2008, a trademark application was filed for GENEVIEVE PROTOCOL with the United States Patent and Trademark Office. The USPTO has given the GENEVIEVE PROTOCOL trademark a serial number of 77389950. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, September 9, 2019. This trademark is owned by Epeius Biotechnologies Corporation. The GENEVIEVE PROTOCOL trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services featuring a clinical protocol wherein two distinct tumor-targeted gene vectors, one carrying a cytocidal gene (a mutated cyclin G1), and the other bearing an immunomodulatory cytokine gene (GM-CSF), are used in combination for cancer immunotherapy or cancer vaccination
genevieve protocol

General Information

Serial Number77389950
Word MarkGENEVIEVE PROTOCOL
Filing DateWednesday, February 6, 2008
Status800 - REGISTERED AND RENEWED
Status DateMonday, September 9, 2019
Registration Number3661647
Registration DateTuesday, July 28, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 8, 2008

Trademark Statements

Disclaimer with Predetermined Text"PROTOCOL"
Goods and ServicesMedical services featuring a clinical protocol wherein two distinct tumor-targeted gene vectors, one carrying a cytocidal gene (a mutated cyclin G1), and the other bearing an immunomodulatory cytokine gene (GM-CSF), are used in combination for cancer immunotherapy or cancer vaccination

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 12, 2008
Primary Code044
First Use Anywhere DateWednesday, February 4, 2009
First Use In Commerce DateWednesday, February 4, 2009

Trademark Owner History

Party NameGENVIVO, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN MARINO, CA 91108
Party NameEpeius Biotechnologies Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Marino, CA 91108
Party NameEpeius Biotechnologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Marino, CA 91108
Party NameEpeius Biotechnologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Marino, CA 91108

Trademark Events

Event DateEvent Description
Monday, September 9, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, September 9, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, September 9, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 6, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 27, 2019TEAS SECTION 8 & 9 RECEIVED
Wednesday, January 30, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 28, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, December 9, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 9, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 8, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 17, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 28, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, June 17, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 5, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 2, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 31, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2009NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2009SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 31, 2009STATEMENT OF USE PROCESSING COMPLETE
Monday, March 9, 2009USE AMENDMENT FILED
Tuesday, March 31, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 9, 2009TEAS STATEMENT OF USE RECEIVED
Thursday, November 20, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 20, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 30, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 8, 2008PUBLISHED FOR OPPOSITION
Wednesday, June 18, 2008NOTICE OF PUBLICATION
Monday, June 2, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 2, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 30, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 29, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 29, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 20, 2008ASSIGNED TO LIE
Tuesday, May 20, 2008NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, May 20, 2008EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, May 20, 2008EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, May 16, 2008ASSIGNED TO EXAMINER
Tuesday, February 12, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

protocol genevieve gene cancer bearing other cyclin immunomodulatory used vaccination immunotherapy combination